vialroom

#retatrutide 2025-03-19

Wednesday35 messages7 participantstimes are UTC
Highlights from this day
  • ferrous_ash — phase 2 was still trending at the end which is why the phase 3 readout matters more than usual 22:59
  • ferrous_ash — stopped for 12 months and restarted at half my old dose, the ramp was easier second time, we shall see 23:33
  • sarcopenia_sam — back after 13 months, has anything actually been published since 23:41
  • sarcopenia_sam — while im here i log resting heart rate every morning because of this and its the one number i actually watch, thats one data point 23:46
FA

coming back to this how do people square the research use only framing with logging their own use

TRIUMPH is phase 3

LT

update on the earlier thing appetite suppression at 1 was stronger than my tirzepatide experience at a comparable point

the half life supports weekly dosing and thats what ive done from the start

watching my heart rate

anyone gone above 10 and what changed

no long term data

phase 2 only

the honest position is this has less human evidence behind it than anything else discussed here

PeptideMeter came back 99.2 on one lot and 99.4 on the next from the same MKM, both fine

phase 2 was still trending at the end which is why the phase 3 readout matters more than usual

baseline  58
wk 2      61
wk 4      64
wk 6      67
wk 8      66
wk 10     65   (held dose from wk 7)
👍1
LM

triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history

Cited study
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
New England Journal of Medicine · 2023
48 weeks, dose-ranging. A Phase 2 result is not a safety record.

the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial, we shall see

sat at 2 for 9 months rather than climbing and it kept working, so i never went up

triple agonist meaning GLP-1, GIP and glucagon, have i got that right

quick one does the glucagon arm explain the heart rate or is that unrelated

T5

my resting rate went up 9 bpm in the first month and came back most of the way by month 2

*VendorInvestigate not the other one

RR

unrelated but TRIUMPH is the phase 3 programme, thats the name to search rather than the molecule, take that with a pinch of salt

T5

the heart rate thing is real enough that i mention it whenever someone asks about starting

AA

phase 2 doses are published and theyre not far off what people here run, coincidence rather than plan

FA

did the phase 2 result actually come in higher than the tirzepatide numbers

Cited study
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
New England Journal of Medicine · 2023
48 weeks, dose-ranging. A Phase 2 result is not a safety record.

stopped for 12 months and restarted at half my old dose, the ramp was easier second time, we shall see

baseline  58
wk 2      61
wk 4      64
wk 6      67
wk 8      66
wk 10     65   (held dose from wk 7)

*Medutest not the other one

is there any long term safety data at all or is it phase 2 and hope

low and slow here means smaller steps than i ever used on tirzepatide, thats the received wisdom

SS

back after 13 months, has anything actually been published since

🙏3😂11

while im here i log resting heart rate every morning because of this and its the one number i actually watch, thats one data point

📉12
FA

reconstituted the 5 vial to 2mg/ml specifically so i could take 15 without measuring crumbs